iMaps Capital Markets expands product portfolio with actively managed certificate for AI trading strategy
19.5.2022 09:45:54 CEST | news aktuell GmbH | Pressemelding
Liechtenstein, May 19, 2022 – iMaps Capital Markets (iMaps), a brand of the European structured products issuer iMaps ETI AG, in cooperation with Aiternativ Ltd. launched a new exchange-traded investment product: the Aiternativ Dynamic ETI (ISIN: DE000A3GW617). This exchange-traded instrument uses artificial intelligence in the form of a trading algorithm to control the underlying assets in order to generate reliable returns in the forex markets. It has recently been traded on the Stuttgart Stock Exchange and is approved for public distribution in Germany, Liechtenstein, Luxembourg, Spain, Portugal and Austria.
The investment strategy represented by this innovative certificate is based on the total return approach and thus aims to always achieve positive returns with limited risk and to secure the profits already made. Investments are made exclusively in contracts for difference (CFDs), i.e. derivative products, on the foreign exchange market (FOREX). The strategy is based on an automated trading system that identifies, evaluates and, if necessary, trades in short-term volatility breakouts. Aiternative Ltd. developed this system based on strict risk management principles.
In the underlying asset of the actively managed ETI, currencies and contracts for difference can be used for both appreciation (long positions) and depreciation (short positions) assumptions. As a result, it enables extensive flexibility and a return that is independent of the general stock and bond markets.
“I am pleased that we can now add another thematic exchange traded product to our portfolio, which is based on active currency management. Since the currency markets hardly correlate with classic shares and bonds, interesting diversification effects arise,” explains Andreas Woelfl, founder and Chairman of iMaps ETI AG. "The automated investment solution controlled by artificial intelligence, in combination with the total return approach, ensures reliable returns on the foreign exchange markets with a moderate risk profile."
“We are delighted to be listed on the Stuttgart Stock Exchange in partnership with iMaps Capital Markets. This is an important milestone for our company and a great step to build on our long-term vision to become a leading provider of artificial intelligence based trading systems,” said Hugo Malhoa, Head of Business Development at Aiternativ Ltd.
About iMaps ETI AG
iMaps ETI AG is an issuer of Exchange Traded Products (ETP) in the Principality of Liechtenstein with a focus on asset manager certificates in the form of Actively Managed Certificates.
iMaps Capital Markets focuses on providing asset managers with the platform for issuing Exchange Traded Instruments (ETI) as a white label solution in order to map the respective investment strategy. The spectrum represents both ETIs on classic investments such as shares, derivatives and funds, as well as on digital assets as an underlying. As a subgroup of Exchange Traded Products, they are an interesting, rapidly growing and cost-effective alternative to funds. Thanks to the approved securities prospectus of iMaps ETI AG, there is also the possibility of publicly offering ETIs to private investors.
For more information, visit: www.imaps-capital.com
About Aiternative
Aiternative Ltd. is a Swiss investment advisor to A.R. Suisse Financial GmbH.
Aiternativ's system uses a sophisticated automated trading tool that offers a range of investment opportunities that help investors capitalize on the power of compound interest. An important part of the system works through high-frequency, low-volume (HFLV) transactions. This means that while there are potentially hundreds of opportunities for a successful trade over the lifetime of the investment, only a tiny percentage of the account is used for the trades with the highest probability of success.
With the help of big data, AI and machine learning, historical performance data from numerous data points can be used effectively to better predict future price fluctuations and automatically react to them more effectively.
For more information, visit: www.aiternativ.com.
Contact:
public imaging GmbHGoldbekplatz 3, 22303 HamburgCharlotte Brigitte Looß /
Isabella von Köckritz
Tel.: +49 (0) 40 401999-292 / - 22
E-Mail: imaps@publicimaging.de
Om news aktuell GmbH
news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.
Følg pressemeldinger fra news aktuell GmbH
Registrer deg med din e-postadresse under for å få de nyeste sakene fra news aktuell GmbH på e-post fortløpende. Du kan melde deg av når som helst.
Siste pressemeldinger fra news aktuell GmbH
WELEDA x Stella McCartney: Paris Fashion Week / Skin Food: 100 years of loving skin9.3.2026 13:53:38 CET | Press release
Arlesheim, 09th March 2026 During this season’s Paris Fashion Week, WELEDA is backstage at the Stella McCartney show ensuring radiant skin: make-up artists draw specifically on the trusted nurturing power of the WELEDA Skin Food range to prep and prime the runway models’ skin perfectly for make-up and create a natural glow.
Grünenthal licenses exclusive South Korean rights to Qutenza® to BCWorld Pharm5.3.2026 08:54:06 CET | Press release
Aachen, Germany & Yeoju, South Korea, 5 March 2026 – Grünenthal, a global leader in pain management and related diseases, and BCWorld Pharm Co., Ltd. ("BCWP"), a specialty company actively expanding and diversifying its pain management portfolio through global open innovation partnerships, announced today that they have entered into a definitive agreement whereby BCWP will have the exclusive South Korean rights to Qutenza®, a topical, non-systemic, non-opioid patch treatment. In Europe, the product is indicated for the management of peripheral neuropathic pain.
Compax MVNE continues to support Airalo’s eSIM platform2.3.2026 14:46:10 CET | Press release
Compax, a leading solution provider in the MVNO and telco space, will continue to support Airalo, the world’s first and largest eSIM platform.
Grünenthal takes full ownership of Grünenthal Meds, the joint venture established with Kyowa Kirin for its established medicines brands2.3.2026 10:39:09 CET | Press release
Grünenthal acquired Kyowa Kirin International’s 49% stake in ‘Grünenthal Meds’, a joint venture formed in 2023 to market the established medicines portfolio from Kyowa Kirin International. Through this acquisition, Grünenthal assumes the sole responsibility of a portfolio comprising 12 brands across six therapeutic areas and >60 markets.
Valle Venia presents new song by LPS feat. Lara: Where will it take me27.2.2026 10:15:00 CET | Press release
The song describes the challenge of trusting the flow, relying on oneself, following one's own values with confidence.
I vårt presserom finner du alle våre siste pressemeldinger, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.
Besøk vårt presserom
